Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2010
10/27/2010EP2243474A1 Propective effect of thymoquinome in sepsis
10/27/2010EP2242768A2 Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
10/27/2010EP2242763A1 Anti-bacterial compositions
10/27/2010EP2242758A1 Crystalline form of abacavir that is essentially free of solvent
10/27/2010EP2242752A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
10/27/2010EP2242751A1 Heterocyclic derivatives as hepatitis c virus inhibitors
10/27/2010EP2242750A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors
10/27/2010EP2242743A1 Aminopyrazole derivatives
10/27/2010EP2242488A2 Amino acid derivatives used as pharmaceutical substances
10/27/2010EP2099761B1 Antibacterial quinoline derivatives
10/27/2010EP2041145B1 Azatricyclic compounds and their use
10/27/2010EP1537147B1 Antibody anti hla-dr with an increased adcc and inducing cytokine production
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1305036B1 Nutritional composition
10/27/2010EP0979101B1 Recombinant canine adenovirus 2 (cav2) containing exogenous dna
10/27/2010CN201612864U 壳聚糖包覆药物缓释微球 Chitosan microspheres coated drug delivery
10/27/2010CN1912141B Identification of genes
10/27/2010CN1898231B Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1384877B Rescue of mumps virus from cDNA
10/27/2010CN101874035A Novel sulfated oligosaccharide derivatives
10/27/2010CN101874032A Novel naphthyridine derivative monohydrate and method for producing the same
10/27/2010CN101873861A Composition for preventing virus infection comprising poly-gamma-glutamic acid
10/27/2010CN101870986A Efficient production method and application of antibacterial peptide plectasin
10/27/2010CN101870978A Clostridium difficile exotoxin A carboxy-terminal gene sequence with optimized codon and nucleic acid vaccine thereof
10/27/2010CN101870769A PEG (Polyethylene Glycol), mPEG (Methoxy Polyethylene Glycol) chemical modifier and method thereof for preparing water-soluble resveratrol prodrug
10/27/2010CN101870768A Polyethylene glycol derivatives of activated lactone compounds
10/27/2010CN101870733A Poultry IL-2 and newcastle disease virus HN gene recombination fusion protein and application thereof
10/27/2010CN101870704A Method for purifying cefotetan acid crude products
10/27/2010CN101870701A Bergenin isopentene group derivative and preparation method and application thereof
10/27/2010CN101870691A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
10/27/2010CN101870689A 3-(1-halogenated methylene) sulphur chromane-4-ketone compound as well as preparation method and application thereof
10/27/2010CN101870655A Preparation method of Terbinafine hydrochloride
10/27/2010CN101869714A Therapeutic agent for infections
10/27/2010CN101869707A Methods for enhancing innate and adaptive immunity and antigen immunogenicity
10/27/2010CN101869705A Streptococcus iniae vaccine and preparation and application thereof
10/27/2010CN101869704A Single dose immunization against tetanus toxin cation dextran microspheres and preparation method thereof
10/27/2010CN101869702A Vaccine produced by suspended microcarrier cell culture system and method for producing vaccine
10/27/2010CN101869693A Traditional Chinese medicine for treating nongonococcal urethritis
10/27/2010CN101869672A Moxibustion liquid and preparation process thereof
10/27/2010CN101869654A Chinese medicinal pills for treating scrofula
10/27/2010CN101869648A Medicament for treating AIDS and improving human immunologic function and preparation method thereof
10/27/2010CN101869647A Method for preparing Chinese medicinal lotion for treating early plmar pustule
10/27/2010CN101869642A Chinese medicinal composition
10/27/2010CN101869637A Medicament for treating rheumatism arthritis and preparation method thereof
10/27/2010CN101869626A Chinese medicinal compound preparation private care liquid, and preparation and application thereof
10/27/2010CN101869622A External patch for treating female pelvic inflammation and preparation method thereof
10/27/2010CN101869621A Composition with antimicrobial, immunity improving and anti-inflammatory effects
10/27/2010CN101869619A Medicament for treating tinea corporis and preparation method thereof
10/27/2010CN101869611A Admixture capable of repelling chicken coccidiosis and stopping dysentery and preparation method thereof
10/27/2010CN101869606A Method for preparing food-care essential oil
10/27/2010CN101869601A External veterinary medicament
10/27/2010CN101869597A Medicinal composition
10/27/2010CN101869595A Preparation method and quality detection method of liquorice and gall oral liquid
10/27/2010CN101869593A Detection method of pill capable of dissipating phlegm and stopping coughing
10/27/2010CN101869591A Method for producing alkannin by utilizing Arnebia euchroma(Royle)Johnst hairy root
10/27/2010CN101869585A Composition for assisting treatment effect of hepatitis B medicament
10/27/2010CN101869579A AIDS virus lytic enzyme
10/27/2010CN101869577A Bear gall macromolecular extract and preparation method and application thereof
10/27/2010CN101869571A Doxycycline hydrochloride and rifampicin effervescent granules for livestock and poultry and preparation method thereof
10/27/2010CN101869569A Ready-to-use entecavir composite
10/27/2010CN101869568A Use of autophagy (B-cell apoptosis) inhibitor
10/27/2010CN101869563A Peptide deformylase inhibitor containing 4-methylene pyrrolidine
10/27/2010CN101869561A Tacrolimus-containing improved release composition
10/27/2010CN101869550A Oral sustained-release dry suspension taking clarithromycin as main ingredient
10/27/2010CN101869549A Oral sustained-release dry suspension taking roxithromycin as main ingredient
10/27/2010CN101869548A Oral sustained-release dry suspension taking azithromycin as main ingredient
10/27/2010CN101869444A Water-replenishing bactericidal wet tissue
10/27/2010CN101869181A Preparation method of bacillus polymyxa raw powder with 100 billion live spores per gram
10/27/2010CN101869172A Production method of active eel peptide
10/27/2010CN101579527B HLA Specific human cytomegalovirus Multi-epitope adenovirus DNA Vaccine of Chinese population
10/27/2010CN101564389B Application of arbidol hydrochloride in preparing medicine for preventing and treating canine distemper virus
10/27/2010CN101297967B Novel use of staphylococcus enterotoxin A gene
10/27/2010CN101264087B Medicinal composition containing cefpodoxime proxetil cyclodextrin inclusion compound and preparation thereof
10/27/2010CN101249261B Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same
10/27/2010CN101181247B Biphenyl benzyl azoles aerosol and preparation method thereof
10/27/2010CN101070542B Intensified tubercle-resisting action of human interleukin 24
10/27/2010CN101020894B Avirulent type-2 pig streptococcus strain and its prepn and application
10/26/2010USRE41894 Hepatitis C inhibitor tri-peptides
10/26/2010US7820823 Dual action antibiotics
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820786 Synthetic peptides and uses therefore
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820715 Chemical intermediates; neurodegenerative disorders
10/26/2010US7820714 Increased selectivity for sialic acid binding Ig-like lectins (Siglec); improving immune response dependent on B-cells
10/26/2010US7820697 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline; treatment of cancers, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, Crohn's disease and viral disease
10/26/2010US7820671 Peptidomimetic protease inhibitors
10/26/2010US7820660 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/26/2010US7820650 active mainly against dermatophytes
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/26/2010US7820632 For inhibiting expression of human immunodeficiency virus (HIV); for use in vitro/vivo
10/26/2010US7820631 For prophylaxis and therapy of viral infection for example by varicella zoster virus (VZV)
10/26/2010US7820627 with core structure of pentaerythritol used as replacement for sugars; immunomodulators; immunogens within liposomes; tumor antigens; for use as haptens, inhibitors of bacterial-host cell adhesion; septic shock
10/26/2010US7820619 potentiate antimicrobial functions of leukocytes such as neutrophils; lower inherent mammalian cell toxicities, improved immunogenicity and shortness of duration of effectiveness due to biodegradation, retaining activity in plasma and serum; antibiotic resistance; pharmacokinetics
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010US7820436 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820395 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads
10/26/2010US7820375 Use of a protein of the CRMP family for treating diseases related to the immune system
10/26/2010US7820161 Treatment of autoimmune diseases
1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 1798